|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 14/54 | (2006.01) |
| C07K 14/54 | (2013.01) | ||
| A61K 47/60 | (2017.01) | ||
| A61K 47/6813 | (2017.08) | ||
| A61K 47/54 | (2017.01) | ||
| A61K 47/6849 | (2017.08) | ||
| A61P 35/00 | (2018.01) | ||
| A61K 38/20 | (2013.01) |
| (11) | Patento numeris | 4029877 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 21217086.4 |
| Europos patento paraiškos padavimo data | 2018-08-03 | |
| (97) | Europos patento paraiškos paskelbimo data | 2022-07-20 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2024-01-17 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 201762540692 P | 2017-08-03 | US | |
| 201862616733 P | 2018-01-12 | US |
| (72) |
ALI, Khaled, M.K.Z. , US
AGRAWAL, Neeraj, Jagdish , US
KANNAN, Gunasekaran , US
FOLTZ, Ian , US
WANG, Zhulun , US
BATES, Daren , US
MOCK, Marissa , US
TAKENAKA, Shunseke , US
|
| (73) |
Amgen Inc. ,
One Amgen Center Drive, Thousand Oaks, CA 91320-1799,
US
|
| (54) | INTERLEUKIN-21 MUTEINS AND METHODS OF TREATMENT |
| INTERLEUKIN-21 MUTEINS AND METHODS OF TREATMENT |